• 简

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Siegfried Holding (SWX:SFZN) Could Be 27% Undervalued As It Names A New COO

    Simply Wall St·07/29/2026 01:29:50
    语音播报

    Siegfried Holding (SWX:SFZN) has drawn investor attention after appointing Eduardo Montanha as Chief Operating Officer, consolidating oversight of Drug Substances and Drug Products into a single leadership role.

    See our latest analysis for Siegfried Holding.

    At a share price of CHF72.85, Siegfried Holding has seen a 1 month share price return of 4.07%, while the 1 year total shareholder return is down 22.43%. This suggests that recent momentum contrasts with weaker longer term results as investors reassess the outlook following leadership changes.

    If you are considering how Siegfried's move fits into wider opportunities in healthcare manufacturing and services, it can be useful to broaden your search with founder led compounders via the 106 top founder-led companies

    Siegfried Holding trades well below the average analyst price target and also sits beneath one intrinsic value estimate, even after the recent COO driven share price uptick. Does that gap signal an opportunity or a value trap as expectations reset?

    Most Popular Narrative: 26.5% Undervalued

    The most followed Siegfried Holding narrative pegs fair value at CHF99.18, which sits well above the last close at CHF72.85 and frames the current discount.

    The accelerating trend of pharmaceutical outsourcing, particularly among small and mid-sized pharma companies that lack in-house manufacturing capabilities, positions Siegfried to capture increased volumes and long-term contracts, directly supporting top-line revenue growth and underpinning forward sales visibility.

    Read the complete narrative. Read the complete narrative.

    Analysts are not just sketching a simple growth story. Their fair value hinges on a specific mix of revenue expansion, margin shaping and a future earnings multiple that all need to line up. Curious which of those levers does the heavy lifting in this narrative on Siegfried Holding?

    Result: Fair Value of CHF99.18 (UNDERVALUED)

    Have a read of the narrative in full and understand what's behind the forecasts.

    However, Siegfried Holding's story could change quickly if pricing pressure on customers leads to lower margins or if new capacity, such as Minden, ramps more slowly than expected.

    Find out about the key risks to this Siegfried Holding narrative.

    Another View on Siegfried Holding Using Cash Flows

    The analyst narrative suggests Siegfried Holding looks around 26.5% undervalued at CHF99.18 versus the current CHF72.85. Our DCF model points in the opposite direction. It indicates the shares trade above an estimated cash flow value of about CHF58.75, which leans more toward overvaluation. Which anchor do you treat as your starting point?

    Look into how the SWS DCF model arrives at its fair value.

    SFZN Discounted Cash Flow as at Jul 2026
    SFZN Discounted Cash Flow as at Jul 2026

    Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Siegfried Holding for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 244 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

    Next Steps

    If the mixed signals around Siegfried Holding leave you unsure, move quickly to review the facts, weigh both sides, and decide where you stand with the 4 key rewards and 1 important warning sign.

    Looking for more investment ideas beyond Siegfried Holding?

    If Siegfried Holding has caught your interest, do not stop here. Use the Simply Wall St screener to quickly surface other stocks that could suit your approach.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.